ArticleStem cell reviews and reports2023

Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up.

Ahlke Heydemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.